Navigation Links
Ahram Biosystems Announces Launch of the New Economy Model F1-12 of Its Palm PCR Series
Date:4/23/2012

SANTA CLARA, Calif., April 23, 2012 /PRNewswire/ -- Ahram Biosystems, Inc., a leading innovator of new life science tools, today announced the launch of Palm PCR F1-12, the economy model of its innovative portable PCR system. The F1-12 system is a cost-effective, high-performance portable PCR system, delivering PCR amplification with high speed and sensitivity in a fully portable format.

The Palm PCR F1-12 system provides three "Standard Fast" speed levels delivering 30-cycle PCR amplification within 30 minutes down to 24 minutes. The amplification sensitivity reaches to near single-copy level below 10 copies. The dynamic range of the PCR amplification is up to 1 kbp. Like other Palm PCR series, it is battery-powered (more than 4 hours of continuous operation on a single charge) and represents high temperature uniformity (less than +/- 0.1 degrees C) and a small footprint and light weight (71 mm x 121 mm x 47 mm or 2.8" x 4.76" x 1.85", 350 g).

The high speed and high sensitivity of the F1-12 system and its affordable price make it ideal for a wide range of downstream applications that require fast and sensitive nucleic acid amplification. Examples include POCT (point-of-care testing), food quality assurance, forensics, educational uses and many other applications of genetic identification purposes. The battery-powered, full portability makes the F1-12 system particularly invaluable where in-field or on-site PCR amplification is crucial. The Palm PCR F1-12 system enables users to perform highly sensitive and accurate PCR amplification in a fully portable format while saving both money and time.

The Palm PCR F1-12 system comes at an affordable price of mid US$3k, in a complete set that includes the main device, a rechargeable battery and other accessories. The F1-12 system is available for order from Ahram Biosystems (www.ahrambio.com) or its global distributors.

About Ahram Biosystems:

Ahram Biosystems, Inc. is a leading innovator of new life science tools, taking the initiative to bring portable innovation to the biotechnology market. The company provides the innovative portable PCR system, Palm PCR(TM), designed to perform polymerase chain reactions for both indoor and outdoor applications. The company has its headquarters in Seoul, Korea and a subsidiary in Santa Clara, California. For more information, visit www.ahrambio.com or contact info@ahrambio.com.


'/>"/>
SOURCE Ahram Biosystems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. PEG-Liposome siRNA In Vivo Transfection Kit From Altogen Biosystems
2. Glycosan BioSystems Seeks CE Mark in the European Union for HyStem-Rx, a Unique, Implantable Scaffold for Tissue Engineering
3. New Online Tutorials for NCBI resources BioSystems and DCODE
4. Microbix Biosystems Re-files Annual Results With OSC
5. Microbix Biosystems Provides a Corporate Update
6. Celtic Pharma Holdings Announces Investment in Novacta Biosystems Limited
7. Penguin Computing Forms OEM Agreement with Applied Biosystems for Scyld ClusterWare
8. WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound Healing Research
9. Prosolia and Indigo BioSystems Come Together to Create FireFly(TM) Data Conversion Software for Mass Spectrometers
10. Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research
11. Cyprotex Purchases Applied Biosystems Sciex QTRAP(R) 5500 LC-MS/MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... March 22, 2017   iSpecimen ┬«, the ... Doctors Pathology Service (DPS), a full-service anatomic ... the United States , has joined a ... Information Network (DHIN) to make human biospecimens and ... The novel program, announced in 2015 as a collaboration ...
(Date:3/22/2017)... , March 22, 2017   Boston Biomedical , ... therapeutics designed to target cancer stemness pathways, today announced ... Andrews as Chief Executive Officer, effective April 24, ... Chiang J. Li , M.D., FACP, who has led ... ago. Under his leadership, Boston Biomedical has grown from ...
(Date:3/22/2017)... ... March 21, 2017 , ... Proper glycosylation is critical for ... increase and/or decrease in antibody-dependent cellular cytotoxicity or complement-dependent cytotoxicity, there is a ... , To meet this demand, the team at SCIEX has developed a ...
(Date:3/22/2017)... ... March 21, 2017 , ... ... ) has unveiled its innovative Quantum peristaltic pump with patented ReNu single-use ... sets the new standard for high-pressure feed pumps in SU tangential flow ...
Breaking Biology Technology:
(Date:3/2/2017)... , March 2, 2017 Summary ... better understand Merck KGaA and its partnering interests and ... https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals and Alliance ... partnering activity of one of the world,s leading life ... prepared upon purchase to ensure inclusion of the most ...
(Date:2/28/2017)... ANGELES , Feb. 28, 2017   Acuant ... verification software globally, announces significant enhancements to new and ... May 2016. New products include mobile and desktop Acuant ... DocX TM - a real time manual review ... core idScan┬« technology provides the fastest and most accurate ...
(Date:2/26/2017)... Feb. 25, 2017  Securus Technologies, a leading ... for public safety, investigation, corrections and monitoring, announces ... Reentry. "Too often, too many offenders ... county jails are trying to tackle this ongoing ... friends and family members. While significant steps are underway, ...
Breaking Biology News(10 mins):